Article Information
PubMed
Published By
History
- Received June 5, 2014
- Revision received September 22, 2014
- Accepted September 26, 2014
- First published November 12, 2014.
- Version of record published November 12, 2014.
Copyright & Usage
Copyright © 2014 the authors 0270-6474/14/3315382-12$15.00/0
Author Information
Author contributions
Author contributions: A.A., E.H., and N.S. designed research; A.A., Y.H., P.S., and N.E. performed research; A.A., Y.H., P.S., N.E., and N.S. analyzed data; A.A. and N.S. wrote the paper.
Disclosures
- Received June 5, 2014.
- Revision received September 22, 2014.
- Accepted September 26, 2014.
This work was supported by a grant from the Lulu P. & David J. Levidow Fund for Alzheimer's Disease and Neuroscience Research. Additional funding came from the James S. McDonnell Foundation and from the Israeli Center for Excellence in Cognitive Science.
The Weizmann Office for Technology Licensing is currently deliberating whether to file for a patent regarding a treatment for addiction based on the currently described results. The authors declare no other competing financial interests.
- Correspondence should be addressed to Anat Arzi, Department of Neurobiology, Weizmann Institute of Science, Rehovot, 7610001, Israel. Anat.arzi{at}gmail.com
Online Impact
